Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2020 15:09 ET | Source: Algernon Pharmaceuticals

Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
April 29, 2020 08:30 ET | Source: Algernon Pharmaceuticals

Algernon Presents “The Science of Ifenprodil” on a Special BioPub Webcast Hosted by Dr. KSS, MD, PhD

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage...
April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

アルジェノン、韓国で実施するCOVID-19治療薬としてのイフェンプロジル第II相臨床試験に規制当局による承認と倫理審査による承認を取得

ブリティッシュコロンビア州バンクーバー発, April 24, 2020 (GLOBE NEWSWIRE) -- 臨床病期向け治療薬開発会社のアルジェノン製薬 (Algernon Pharmaceuticals Inc.) (CSE: AGN) (フランクフルト証券取引所: AGW) (OTCQB: AGNPF) (以下、「同社」または「アルジェノン」)...
April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

Algernon 獲得在韓國進行第 2 期 Ifenprodil 的 COVID-19 人類研究的監管和倫理批准

卑詩省溫哥華, April 24, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF)（下稱「公司」或「Algernon」）是一家臨床階段的藥物開發公司，現欣然宣佈已獲得韓國食品和藥物安全部的批准，並已獲得倫理機構批准進行研究人員主導的 NP-120...
April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

Algernon的艾芬地尔第二阶段新冠肺炎人类研究在韩国获得监管和伦理审批

不列颠哥伦比亚省温哥华, April 24, 2020 (GLOBE NEWSWIRE) -- 临床阶段药物开发企业Algernon Pharmaceuticals Inc.（CSE: AGN）（FRANKFURT: AGW）（OTCQB:...
April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

Algernon obtiene aprobación regulatoria y de ética para estudio en Fase II de Ifenprodil en seres humanos con COVID-19 en Corea del Sur

VANCOUVER, Columbia Británica, April 24, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (la “Compañía” o “Algernon”), una empresa de...
April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

Algernon erhält in Südkorea Genehmigung der Regulierungsbehörde und Ethikkommission für seine Phase-II-Humanstudie zu Ifenprodil in der Behandlung von COVID-19

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das „Unternehmen“ oder „Algernon“), ein auf die klinische...
April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

Algernon reçoit une approbation réglementaire et éthique pour l'étude humaine de phase 2 sur l'ifenprodil dans le cadre du traitement du COVID-19 en Corée du Sud

VANCOUVER, Colombie-Britannique, 24 avr. 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE : AGN) (FRANCFORT : AGW) (OTCQB : AGNPF) (la « Société » ou « Algernon »), société de...
April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

Algernon Menerima Kelulusan Kawal Selia dan Etika bagi Kajian Manusia COVID-19 Ifenprodil Fasa 2 di Korea Selatan

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“syarikat” atau “Algernon”) sebuah syarikat pembangunan...
April 24, 2020 07:06 ET | Source: Algernon Pharmaceuticals

Algernon Recebe Aprovação Regulatória e de Ética para Estudo de Fase 2 do Ifenprodil COVID-19 Humano na Coreia do Sul

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) -- A Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (a "Empresa” ou “Algernon”), uma empresa de desenvolvimento...